CHARMM Therapeutics

CHARM Therapeutics is a London-based biotechnology company pioneering the use of 3D deep learning to discover small molecule therapeutics for challenging disease targets. The company's core technology, DragonFold, is an end-to-end protein-ligand co-folding algorithm that predicts how small molecules interact with proteins, allowing for the rapid design of candidates against previously "undruggable" targets. Founded in 2021 by Laksh Aithani and Nobel laureate David Baker, the firm focuses primarily on developing transformative medicines for oncology. CHARM is headquartered in London and has secured significant backing from prominent venture capital firms and strategic partners like Bristol Myers Squibb and NVIDIA.